COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02107950
Brief Title: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

First Submitted : April 4, 2014
First Submitted that Met QC Criteria : April 4, 2014
First Posted : April 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : August 13, 2018
Last Update Posted : August 15, 2018